4//SEC Filing
Lichtenstein Chen 4
Accession 0001193125-25-308057
CIK 0000818686other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:01 PM ET
Size
7.2 KB
Accession
0001193125-25-308057
Insider Transaction Report
Form 4
Lichtenstein Chen
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2025-12-02+4,804→ 4,804 total - Exercise/Conversion
Restricted Share Units
2025-12-02−4,804→ 0 total→ Ordinary Shares (4,804 underlying)
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on December 2, 2024 and vested on December 2, 2025.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0002046465
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 4:01 PM ET
- Size
- 7.2 KB